- Report
- October 2024
- 181 Pages
Global
From €3339EUR$3,545USD£2,856GBP
€3710EUR$3,939USD£3,173GBP
- Report
- January 2024
- 116 Pages
Global
From €3500EUR$3,980USD£3,098GBP
- Report
- October 2024
- 270 Pages
China
From €3768EUR$4,000USD£3,222GBP
- Report
- April 2025
- 50 Pages
Global
From €2496EUR$2,650USD£2,135GBP
- Report
- October 2024
- 135 Pages
China
From €1696EUR$1,800USD£1,450GBP
Cephradine is a type of antibiotic used to treat a variety of bacterial infections. It belongs to the cephalosporin class of antibiotics, which are derived from a type of fungus. Cephradine is used to treat infections of the respiratory tract, urinary tract, skin, and soft tissue. It is also used to prevent infections in people who are undergoing certain medical procedures. Cephradine is available in both oral and injectable forms.
The cephradine market is highly competitive, with a number of companies offering various formulations of the drug. Companies in the market include Pfizer, Merck, GlaxoSmithKline, Sanofi, and AstraZeneca. These companies are engaged in research and development of new formulations of cephradine, as well as marketing and distribution of existing products. Show Less Read more